ALNY
ALNY
NASDAQ · Biotechnology

Alnylam Pharmaceuticals Inc

Nasdaq 100 Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks
$155.94
-0.72 (-0.46%)
As of Nov 7, 1:06 AM ET ·
ALNY News4 articles
Alnylam Shares Tumble 28% After Slashing Amvuttra Revenue Forecast
Shares of Alnylam Pharmaceuticals fell 28% after the firm lowered its Amvuttra revenue outlook, erasing $10.9 billion in equity value.
Earnings
Biotech Sector Hit by $15B Loss as Vertex, Ionis Stumble
Vertex and Ionis shares slumped after setbacks, erasing $14.8B in market cap. Crinetics, BridgeBio, and Vera gained $6.1B combined.
Markets
Ionis Plunges 23% After Wainua Misses Key Goal in Heart Disease Trial
Ionis stock tumbled 23% after Wainua missed its primary endpoint in a major heart disease trial, erasing $3.2 billion in market value. The setback shifts attention to the company's TRYNGOLZA launch.
Markets
Recursion Stock Surges Ahead of Goldman Sachs Conference Amid AI Drug Discovery Buzz
Recursion shares surged 12% to $3.87 on heavy volume ahead of a Goldman Sachs conference, as investors await updates on clinical trials, cash runway, and partnerships amid a broader AI drug-discovery rally.
Technology